nach oben

CNS Drugs

Erschienen in:

01.06.2002 | Original Research Article

Pharmaceutical Company Internet Sites As Sources of Information About Antidepressant Medications

verfasst von: Dr Mark A. Graber, Michelle Weckmann

Erschienen in: CNS Drugs | Ausgabe 6/2002

Einloggen, um Zugang zu erhalten

Abstract

Abstract Objective: To determine the informational content of nine pharmaceutical company websites about the antidepressant medication marketed by the company.

Method: A structured, explicit review of materials found on pharmaceutical company websites about nine antidepressants for which no generic drug is available was conducted using eight popular search engines. The accessibility of these websites was also determined using these search engines.

Results: Of 72 searches (one for each drug using each search engine), 46 yielded the pharmaceutical company website within the top 10 links. When outliers were removed, the company website was found in the top 10 links for 45 of 56 searches. All of the websites contain information of an advertising and emotive nature. Of the nine company websites, three contain anecdotal information; only two mention electroconvulsive therapy and four mention other types of drug therapy; and only one mentions the tradenames of other drugs. None of the websites mention drug costs, only one has efficacy statistics for the company’s drug and, although all of the websites mention at least one adverse effect of the company’s drug, only one lists percentages for adverse effects.

Conclusion: The information about drugs for treating depression on pharmaceutical company websites aimed at consumers is limited and makes it difficult for consumers to compare drugs.

Use of tradenames is for product identification only and does not imply endorsement.

Fox S, Rainie L. Pew Charitable Trust Internet and American Life Study [online]. Available from URL: http://www.pewinternet.org/reports/chart.asp?.img=6_daily_activities.jpg [Accessed 2001 Apr 19]

Fox S, Rainie L. Pew Charitable Trust Internet and American Life Study [online]. Available from URL: http://www.pewinternet.org/reports/chart.asp?.img=6_internet_activities. jpg [Accessed 2001 Apr 10]

NIH CancerTrials [online]. Available from URL: http://cancertrials.nci.nih.gov/ [Accessed 2001 Aug 11]

CDC Travel Information [online]. Available from URL: http://www.cdc.gov/travel/ [Accessed 2001 Aug 11]

MD-Consult [online]. Available from URL: http://www.mdconsult.com [Accessed 2001 Aug 11]

Bell RA, Wilkes MS, Kravitz RL. The educational value of consumer-targeted prescription drug print advertising. J Fam Pract 2000; 49: 1092–8PubMed

Kessler DA. Addressing the problem of misleading advertising. Ann Intern Med 1992; 116: 950–1PubMed

Hollon MF. Direct-to-consumer marketing of prescription drugs: creating consumer demand. JAMA 1999; 281: 382–4PubMedCrossRef

Wade VA, Mansfield PR, McDonald PJ. Drug companies’ evidence to justify advertising. Lancet 1989; 2: 1261–4PubMedCrossRef

10.

Anonymous. Drug advertising: is this good medicine? Consum Rep 1996 Jun; 61 (6): 62-3

11.

Griffiths KM, Christensen H. Quality of web based information on treatment of depression: cross sectional survey. BMJ 2000; 321: 1151–5CrossRef

12.

Rhoades R, editor. The Pharmacy Times [online]. Available from URL: http://www.pharmacytimes.com/top200.shtml [Accessed 2001 Aug 1]

13.

SearchEngineWatch.com. The Major Search Engines (updated 22 Jan 2002) [online]. Available from URL: http://searchenginewatch.com/links/major.html [Accessed 2002 Feb 2]

14.

Sullivan D. Jupiter Media Metrix Search Engine Ratings (updated 19 Feb 2002) [online]. Available from URL: http://searchenginewatch.com/reports/mediametrix.html [Accessed 2002 Feb 21]

15.

Foltz A, Sullivan J. Readability level, learning presentation preference, and desire for information among cancer patients. J Cancer Educ 1996; 11: 32–8PubMed

16.

Murphy PW. Reading ability of parents compared with readability level of pediatric patient education materials. Pediatrics 1994; 93: 460–8PubMed

17.

Wilson FL. Measuring patients’ ability to read and comprehend: a first step in patient education. Nursingconnections 1995; 8: 17–25PubMed

18.

Estey A, Musseau A, Keehn L. Patient’s understanding of health information: a multihospital comparison. Patient Educ Couns 1994; 24: 73–8PubMedCrossRef

19.

Siegel D, Lopez J. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? JAMA 1997; 278: 1745–8PubMedCrossRef

20.

Liebman H. Consumer, heal thyself: ads for prescription drugs are popping up more frequently in consumer media. Mediaweek 1993; 3: 12

21.

Bell RA, Wilkes MS, Kravitz RL. Advertisement-induced prescription drug requests: patients’ anticipated reactions to a physician who refuses. J Fam Pract 1999; 48: 446–52PubMed

22.

Spurgeon D. Doctors feel the pressure from direct to consumer advertising. West J Med 2000; 172: 60PubMedCrossRef

23.

Holmer AF. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA 1999; 281: 380–2PubMedCrossRef

24.

Seals TD, Keith MR. Influence of patient information leaflets on anticonvulsant drug compliance in prison. Am J Health Syst Pharm 1997; 54: 2585–7PubMed

25.

Lowe CJ, Raynor DK, Courtney EA, et al. Effects of self medication programme on knowledge of drugs and compliance with treatment in elderly patients. BMJ 1995; 310: 1229–31PubMedCrossRef

26.

Likar LL, Panciera TM, Erickson AD, et al. Group education sessions and compliance with nasal CPAP therapy. Chest 1997; 111: 1273–7PubMedCrossRef

27.

Haynes RB, McKibben KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996; 348: 383–6PubMedCrossRef

28.

Powell KM, Edgren B. Failure of educational videotapes to improve medication compliance in a health maintenance organization. Am J Health Syst Pharm 1995; 52: 2196–9PubMed

Titel: Pharmaceutical Company Internet Sites As Sources of Information About Antidepressant Medications
verfasst von: Dr Mark A. Graber
Michelle Weckmann
Publikationsdatum: 01.06.2002
Verlag: Springer International Publishing
Erschienen in: CNS Drugs / Ausgabe 6/2002
Print ISSN: 1172-7047
Elektronische ISSN: 1179-1934
DOI: https://doi.org/10.2165/00023210-200216060-00005

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2002

Morphological Brain Changes in Depression

Practical Approaches to Migraine Management

Spotlight on Paroxetine in Psychiatric Disorders in Adults

SUNCT Syndrome